Semaglutide Extended-release for Injectable Suspension, 1 mg
15403/23-24
Phase 1 small_molecule active
Quick answer
Semaglutide Extended-release for Injectable Suspension, 1 mg for Diabetes Mellitus, Type 2 is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active